Policy

The U.S. Preventive Services Task Force highlights key research gaps in their recommendations intended to promote public health for all.

Brooks-LaSure describes achievements in her final national leadership call.

Study shows that most beneficiaries skip comparing Part D plans that might better suit their needs and their wallet

A recent market analysis outlined the lack of adequate health insurer competition in many U.S. markets.

How many people will be affected if Congress does not extend premium tax credits for ACA insurance?

Famed television host will join RFK Jr. ‘to take on the illness industrial complex,’ president-elect says in news reports.

Study shows that ownership model matters when it comes to caregiver satisfaction, and that doctors should know the ownership structure of hospices.

The AMA Interim Meeting of the House of Delegates was held November 8-12, in Orlando, Florida. Here is everything you might have missed.

From promises of widespread forgiveness to halted payments, followed by a chaotic mess of legal disputes over repayment plans, federal student loan borrowers are on an emotional rollercoaster.

Some states have few or no hospitals with ‘A’ grades for patient safety, according to the Leapfrog Group’s fall 2024 report card.

Emma Schuering, JD, of the Polsinelli law firm discusses non-compete agreements in health care.

As we prepare for a new Congress in January, it’s essential to ensure legislators and their staff fully understand the implications of nuclear medicine policy shifts on patient care and medical innovation.

Trump taps vaccine skeptic Kennedy at HHS to 'make America healthy again.'

CPI up 0.2% for the month, up to 2.6% overall

Antitrust chief says the nation is at an inflection point to restore competition or pay more money for less choice and more aggravation.

Study finds spreading medical misinformation is low on the list of reasons for disciplinary actions against physicians in recent years.

In a recent announcement, the AMA announced its support of more standardization and regulation of nonprofit hospitals.

New policy would ensure AMA support for a federal prohibition on the inappropriate denial of payment for care that is necessary and has received prior authorization.

Revenue is increasing but physicians and providers are working more while generating less money.

A panel at the Financial Times’ 2024 Global Pharma and Biotech Summit in London analyzed what the re-election of Trump could mean to the pharmaceutical industry.

A slideshow with physicians elected to the House of Representatives for the next Congress.

A look at what happened in the former president’s first term, and his plans for his second term.

Doctors, ambulatory surgical centers, hospitals all could be affected; plan includes hospital reinvestment for those that need it.

Our guide to getting elected to office and what happens once you get there.

Rep. Greg Murphy, MD, discusses PBMs and new blockbuster antiobesity drugs, and predicts election success for former president Donald Trump.